For: | Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, Gulsun S, Barcin T, Kalkanli S, Dal MS, Ayaz C. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol 2013; 19(48): 9377-9382 [PMID: 24409065 DOI: 10.3748/wjg.v19.i48.9377] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9377.htm |
Number | Citing Articles |
1 |
Chloe L Thio, Nan Guo, Chan Xie, Kenrad E Nelson, Stephan Ehrhardt. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. The Lancet Infectious Diseases 2015; 15(8): 981 doi: 10.1016/S1473-3099(15)00158-9
|
2 |
Haohui Deng, Shuzhen Liang, Min Xu, Li Zhuo, Hongbo Gao, Keng Chen, Yuming Shi, Huihui Li, Qian Jiao, Liansheng Lin, Yan Lei, Huiyuan Liu. Clinical Efficacy and Safety in Telbivudine- or Tenofovir-Treated Hepatitis B e Antigen-Positive Pregnant Women. Antiviral Therapy 2020; 25(1): 33 doi: 10.3851/IMP3345
|
3 |
Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Guglielmo Borgia. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. Expert Review of Anti-infective Therapy 2014; 12(7): 775 doi: 10.1586/14787210.2014.920254
|
4 |
Soheil Tavakolpour, Mohammad Darvishi, Hajar Sadat Mirsafaei, Mojtaba Ghasemiadl. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review. Infectious Diseases 2018; 50(2): 95 doi: 10.1080/23744235.2017.1384957
|
5 |
Golasa Samadi Kochaksaraei, Stephen E. Congly, Trudy Matwiy, Eliana Castillo, Steven R. Martin, Carmen L. Charlton, Carla S. Coffin. Cost‐effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk. Liver International 2016; 36(11): 1604 doi: 10.1111/liv.13139
|
6 |
Suda Tekin Koruk, Ayse Batirel, Sukran Kose, Sila Cetin Akhan, Bilgehan Aygen, Necla Tulek, Çigdem Hatipoglu, Cemal Bulut, Orhan Yıldız, Cahide Sacligil, Fatma Sirmatel, Elif Altunok. Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen‐positive pregnant women. Journal of Obstetrics and Gynaecology Research 2015; 41(12): 1870 doi: 10.1111/jog.12821
|
7 |
Filomena Morisco, Raffaele Bruno, Elisabetta Bugianesi, Patrizia Burra, Vincenza Calvaruso, Alice Cannoni, Nicola Caporaso, Gian Paolo Caviglia, Alessia Ciancio, Silvia Fargion, Alessandro Federico, Annarosa Floreani, Giovanni Battista Gaeta, Maria Guarino, Pietro Invernizzi, Anna Licata, Carmela Loguercio, Giuseppe Mazzella, Felice Petraglia, Massimo Primignani, Kryssia Rodriguez-Castro, Antonina Smedile, Luca Valenti, Ester Vanni, Silvia Vannuccini, Chiara Voltolini, Erica Villa. AISF position paper on liver disease and pregnancy. Digestive and Liver Disease 2016; 48(2): 120 doi: 10.1016/j.dld.2015.11.004
|
8 |
M. H. Hyun, Y.‐S. Lee, J. H. Kim, J. H. Je, Y. J. Yoo, J. E. Yeon, K. S. Byun. Systematic review with meta‐analysis: the efficacy and safety of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus. Alimentary Pharmacology & Therapeutics 2017; 45(12): 1493 doi: 10.1111/apt.14068
|
9 |
Monika Sarkar, Norah A. Terrault. Ending vertical transmission of hepatitis B: The third trimester intervention. Hepatology 2014; 60(2): 448 doi: 10.1002/hep.27145
|
10 |
Mauro Viganò, Massimo Puoti, Pietro Lampertico. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; : 339 doi: 10.1007/978-3-319-22330-8_16
|
11 |
Prevention of Peripartum Hepatitis B Transmission. New England Journal of Medicine 2016; 375(15): 1496 doi: 10.1056/NEJMc1609991
|
12 |
A. Sidney Barritt, Ravi Jhaveri. Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV. Current HIV/AIDS Reports 2018; 15(2): 155 doi: 10.1007/s11904-018-0386-z
|
13 |
Premashis Kar, Anando Sengupta. Synthetic therapeutics for the treatment of hepatitis B during pregnancy. Expert Opinion on Pharmacotherapy 2018; 19(16): 1771 doi: 10.1080/14656566.2018.1527313
|
14 |
Geoffroy Liegeon, Nicole Ngo-Giang-Huong, Nicolas Salvadori, Piyawan Bunpo, Ratchada Cressey, Jullapong Achalapong, Prateep Kanjanavikai, Orada Patamasingh Na Ayudhaya, Sinart Prommas, Thitiporn Siriwachirachai, Prapan Sabsanong, Jean Yves Mary, Gonzague Jourdain. Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus. Journal of Antimicrobial Chemotherapy 2022; 77(4): 1111 doi: 10.1093/jac/dkab490
|
15 |
Bircan Kayaaslan, Rahmet Guner. Adverse effects of oral antiviral therapy in chronic hepatitis B. World Journal of Hepatology 2017; 9(5): 227-241 doi: 10.4254/wjh.v9.i5.227
|
16 |
Huai‐Lung Chang, Wan‐Hsin Wen, Chien‐Nan Lee, Yu‐En Chiu, Chun‐Jen Liu, Mei‐Hwei Chang, Lung‐Huang Lin, Huey‐Ling Chen. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate. Journal of Viral Hepatitis 2022; 29(2): 107 doi: 10.1111/jvh.13628
|
17 |
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International 2016; 10(1): 1 doi: 10.1007/s12072-015-9675-4
|
18 |
Yao Hu, Hui Yu. Prevention strategies of mother‐to‐child transmission of hepatitis B virus (HBV) infection. Pediatric Investigation 2020; 4(2): 133 doi: 10.1002/ped4.12205
|
19 |
Diana di Filippo Villa, Maria-Cristina Navas. Vertical Transmission of Hepatitis B Virus—An Update. Microorganisms 2023; 11(5): 1140 doi: 10.3390/microorganisms11051140
|
20 |
Renee Heffron, Jillian Pintye, Lynn T. Matthews, Shannon Weber, Nelly Mugo. PrEP as Peri-conception HIV Prevention for Women and Men. Current HIV/AIDS Reports 2016; 13(3): 131 doi: 10.1007/s11904-016-0312-1
|
21 |
Jinfeng Liu, Jing Wang, Dongfang Jin, Caijing Qi, TaoTao Yan, Furong Cao, Li Jin, Zhen Tian, Dandan Guo, Ningxia Yuan, Weihong Feng, Shulin Zhang, Yingren Zhao, Tianyan Chen. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus. Journal of Gastroenterology and Hepatology 2017; 32(1): 177 doi: 10.1111/jgh.13436
|
22 |
Sina Ogholikhan, Kathleen Schwarz. Hepatitis Vaccines. Vaccines 2016; 4(1): 6 doi: 10.3390/vaccines4010006
|
23 |
Xiaoxiao Liu, Can Chen, Daixi Jiang, Danying Yan, Yuqing Zhou, Cheng Ding, Lei Lan, Chenyang Huang, Xiaobao Zhang, Lanjuan Li, Shigui Yang. Psychological stress; knowledge, attitude and practice and acceptance of antiviral therapy in pregnant women with hepatitis B in Zhejiang, China: a case comparison study. BMJ Open 2022; 12(3): e055642 doi: 10.1136/bmjopen-2021-055642
|
24 |
Golasa Samadi Kochaksaraei, Abdel A. Shaheen, Cynthia H. Seow, Herman W. Barkema, Carla S. Coffin. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes. Liver International 2022; 42(8): 1712 doi: 10.1111/liv.15249
|
25 |
Panpan Yi, Ruochan Chen, Yan Huang, Rong-Rong Zhou, Xue-Gong Fan. Management of mother-to-child transmission of hepatitis B virus: Propositions and challenges. Journal of Clinical Virology 2016; 77: 32 doi: 10.1016/j.jcv.2016.02.003
|
26 |
Reed A Siemieniuk, Farid Foroutan, Reza Mirza, Jinell Mah Ming, Paul E Alexander, Arnav Agarwal, Olufunmilayo Lesi, Arnaud Merglen, Yaping Chang, Yuan Zhang, Hassan Mir, Elliot Hepworth, Yung Lee, Dena Zeraatkar, Gordon H Guyatt. Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis. BMJ Open 2017; 7(9): e019022 doi: 10.1136/bmjopen-2017-019022
|
27 |
Mustapha Bittaye, Patrick Idoko, Bissallah Ahmed Ekele, Samuel Amenyi Obed, Ousman Nyan. Hepatitis B virus sero-prevalence amongst pregnant women in the Gambia. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3883-9
|
28 |
Hellan Kwon, Anna S. Lok. Viral hepatitis and pregnancy. Clinical Liver Disease 2014; 4(3): 55 doi: 10.1002/cld.367
|
29 |
Malgorzata Pawlowska, Anna Pniewska, Malgorzata Pilarczyk, Dorota Kozielewicz, Krzysztof Domagalski. Prophylaxis of vertical HBV infection. Expert Opinion on Drug Safety 2016; 15(10): 1361 doi: 10.1080/14740338.2016.1211106
|
30 |
Konstantinos Tziomalos, Georgios Neokosmidis, Georgios Mavromatidis, Konstantinos Dinas. Novel insights in the prevention of perinatal transmission of hepatitis B. World Journal of Hepatology 2018; 10(11): 795-798 doi: 10.4254/wjh.v10.i11.795
Abstract(744) |
Core Tip(701) |
Full Article(HTML)(2618)
|
Full Article (PDF)-1237K(356)
|
Full Article (Word)-185K(212)
|
Audio-325K(8)
|
Peer-Review Report-163K(131)
|
Answering Reviewers-87K(178)
|
Times Cited (0)
|
Total Visits (8030)
|
Open
|
31 |
Li‐Wei Fan, Chang Zhao, Yi‐Long Ma. Letter: tenofovir disoproxil fumarate is safe for prevention of mother‐to‐child transmission of hepatitis B virus. Alimentary Pharmacology & Therapeutics 2019; 50(4): 475 doi: 10.1111/apt.15305
|
32 |
Jun-Ze Chen, Zuo-Wei Liao, Fei-Long Huang, Ru-Kui Su, Wen-Bo Wang, Xue-Yuan Cheng, Jie-Qing Chen, Jia-Qi Liu, Zhong Huang. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04479-x
|
33 |
Wenjun Wang, Jingjing Wang, Shuangsuo Dang, Guihua Zhuang. Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus. PeerJ 2016; 4: e1709 doi: 10.7717/peerj.1709
|
34 |
Jia‐Horng Kao, Tarik Asselah, Xiao‐Guang Dou, Kamal Hamed. Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology 2017; 32(1): 73 doi: 10.1111/jgh.13512
|
35 |
Kathryn Rough, George R. Seage, Paige L. Williams, Sonia Hernandez-Diaz, Yanling Huo, Ellen G. Chadwick, Judith S. Currier, Risa M. Hoffman, Emily Barr, David E. Shapiro, Kunjal Patel. Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine. New England Journal of Medicine 2018; 378(17): 1593 doi: 10.1056/NEJMoa1701666
|
36 |
Murat Afyon, Cumhur Artuk. Perinatal Hepatitis B Virüs Bulaşı. Arşiv Kaynak Tarama Dergisi 2016; 25(22109): 304 doi: 10.17827/aktd.237672
|
37 |
Byung-Ho Choe. A disappearing vertical infection: will hepatitis B be a forgotten disease in children?. The Korean Journal of Internal Medicine 2014; 29(3): 296 doi: 10.3904/kjim.2014.29.3.296
|
38 |
Shahnaz Sali, Mohammad Darvishi, Mojtaba GhasemiAdl, Meisam Akhlaghdoust, Azin Mirzazadeh, Somayeh Elikaei Behjati, Hossein Sheikh-Zeinolabedini, Shervin Shokouhi, Soheil Tavakolpour. Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00021
|
39 |
Ahizechukwu C Eke, George U Eleje, Uzoamaka A Eke, Yun Xia, Jiao Liu. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database of Systematic Reviews 2017; 2017(2) doi: 10.1002/14651858.CD008545.pub2
|
40 |
Kenneth K. Mugwanya, Grace John-Stewart, Jared Baeten. Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women. Expert Opinion on Drug Safety 2017; 16(7): 867 doi: 10.1080/14740338.2017.1338271
|
41 |
Wenhui Li, Li Jia, Xin Zhao, Xiaoyuan Wu, Hongxia Tang. Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0847-2
|
42 |
Qingqing Yang, Zhaohui Zhong, Yalan Yang, Yang Ma, Kecelia T. Flomo. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis. Gastroenterología y Hepatología 2020; 43(10): 640 doi: 10.1016/j.gastrohep.2020.03.015
|
43 |
Cynthia Raissa Tamandjou Tchuem, Monique Ingrid Andersson, Charles Shey Wiysonge, Josef Mufenda, Wolfgang Preiser, Susan Cleary. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis. Vaccine 2021; 39(23): 3141 doi: 10.1016/j.vaccine.2021.04.041
|
44 |
Ruma Rajbhandari, Raymond T Chung. Treatment of Hepatitis B: A Concise Review. Clinical and Translational Gastroenterology 2016; 7(9): e190 doi: 10.1038/ctg.2016.46
|
45 |
Lynne M. Mofenson, Rachel C. Baggaley, Ioannis Mameletzis. Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding. AIDS 2017; 31(2): 213 doi: 10.1097/QAD.0000000000001313
|
46 |
Y. Bacq, C. Gaudy-Graffin, S. Marchand. Prévention de la transmission materno-infantile du virus de l’hépatite B. Archives de Pédiatrie 2015; 22(4): 427 doi: 10.1016/j.arcped.2014.12.017
|
47 |
Marieke Bierhoff, Elise J Smolders, Joel Tarning, David M Burger, Rene Spijker, Marcus J Rijken, Chaisiri Angkurawaranon, Rose McGready, Nicholas J White, Francois Nosten, Michèle van Vugt. Pharmacokinetics of Oral Tenofovir Disoproxil Fumarate in Pregnancy and Lactation: A Systematic Review. Antiviral Therapy 2019; 24(7): 529 doi: 10.3851/IMP3341
|
48 |
Yayun Lin, Yan Liu, Guifeng Ding, Lhousseine Touqui, Weimin Wang, Na Xu, Keying Liu, Lingyan Zhang, Dunjin Chen, Yongzheng Wu, Guiqin Bai. Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33833-w
|
49 |
Monique I Andersson, Ruma Rajbhandari, Michael C Kew, Sandro Vento, Wolfgang Preiser, Andy I M Hoepelman, Gerhard Theron, Mark Cotton, Jennifer Cohn, Dieter Glebe, Olufunmilayo Lesi, Mark Thursz, Marion Peters, Raymond Chung, Charles Wiysonge. Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act. The Lancet Global Health 2015; 3(7): e358 doi: 10.1016/S2214-109X(15)00056-X
|
50 |
Jing Wang, Jinfeng Liu, Caijing Qi, Taotao Yan, Furong Cao, Li Jin, Yingli He, Yuan Yang, Shulin Zhang, Tianyan Chen, Yingren Zhao. Efficacy of Tenofovir Disoproxil Fumarate to Prevent Vertical Transmission in Mothers with Lamivudine-Resistant HBV. Antiviral Therapy 2015; 20(7): 681 doi: 10.3851/IMP2981
|
51 |
Won Hyeok Choe, June Sung Lee. Preventing Vertical Transmission of Hepatitis B virus. Korean Journal of Medicine 2014; 87(5): 557 doi: 10.3904/kjm.2014.87.5.557
|
52 |
Huey‐Ling Chen, Chien‐Nan Lee, Chin‐Hao Chang, Yen‐Hsuan Ni, Ming‐Kwang Shyu, Shih‐Ming Chen, Jen‐Jan Hu, Hans Hsienhong Lin, Lu‐Lu Zhao, Shu‐Chi Mu, Ming‐Wei Lai, Chyi‐Long Lee, Hsien‐Ming Lin, Ming‐Song Tsai, Jenn‐Jeih Hsu, Ding‐Shinn Chen, K. Arnold Chan, Mei‐Hwei Chang. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother‐to‐infant transmission of hepatitis B virus. Hepatology 2015; 62(2): 375 doi: 10.1002/hep.27837
|
53 |
Robert S. Brown, Brian J. McMahon, Anna S.F. Lok, John B. Wong, Ahmed T. Ahmed, Mohamed A. Mouchli, Zhen Wang, Larry J. Prokop, Mohammad Hassan Murad, Khaled Mohammed. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis. Hepatology 2016; 63(1): 319 doi: 10.1002/hep.28302
|
54 |
Anick Bérard, Odile Sheehy, Jin-Ping Zhao, Michal Abrahamowicz, Mona Loutfy, Isabelle Boucoiran, Sasha Bernatsky. Antiretroviral combination use during pregnancy and the risk of major congenital malformations. AIDS 2017; 31(16): 2267 doi: 10.1097/QAD.0000000000001610
|
55 |
M. Bierhoff, M. J. Rijken, W. Yotyingaphiram, M. Pimanpanarak, M. van Vugt, C. Angkurawaranon, F. Nosten, S. Ehrhardt, C. L. Thio, R. McGready. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation. International Journal for Equity in Health 2020; 19(1) doi: 10.1186/s12939-020-01268-3
|
56 |
Yuchao Wu, Jinfeng Liu, Yali Feng, Shan Fu, Fanpu Ji, Long Ge, Naijuan Yao, Xufei Luo, Yingren Zhao, Yaolong Chen, Yuan Yang, Tianyan Chen. Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis. Hepatology International 2020; 14(2): 180 doi: 10.1007/s12072-020-10026-0
|
57 |
Claudia M. Espinosa, Ravi Jhaveri. Update on the management of hepatitis B and C infections in the neonatal period. Seminars in Perinatology 2018; 42(3): 185 doi: 10.1053/j.semperi.2018.02.006
|
58 |
Ravi Jhaveri. Prevention of Hepatitis B Virus Vertical Transmission: Time for the Next Step. Pediatrics 2015; 135(5): e1286 doi: 10.1542/peds.2015-0360
|
59 |
Pierre O. Sellier, Sarah Maylin, Béatrice Berçot, Dorothée Chopin, Amanda Lopes, Guy Simoneau, John Evans, Véronique Delcey, Jean-Louis Bénifla, François Simon, Jean-François Bergmann. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women. European Journal of Gastroenterology & Hepatology 2017; 29(3): 259 doi: 10.1097/MEG.0000000000000793
|
60 |
Malika Sharma, Shital Gandhi. Missed opportunities: Peripartum hepatic failure in a Chinese immigrant. Obstetric Medicine 2014; 7(4): 165 doi: 10.1177/1753495X14546519
|
61 |
Seyed Mohammad Hashemi-Shahri, Batool Sharifi-Mood, Manijeh Khalili. Review of the Prevention of the Hepatitis B Virus Infection Transmission From Mother to Child During Pregnancy. International Journal of Infection 2015; 2(3) doi: 10.17795/iji26626
|
62 |
Miwa Kawanaka, Ken Nishino, Hirofumi Kawamoto, Ken Haruma. Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases. World Journal of Gastroenterology 2021; 27(43): 7497-7508 doi: 10.3748/wjg.v27.i43.7497
|
63 |
Qingqing Yang, Zhaohui Zhong, Yalan Yang, Yang Ma, Kecelia T. Flomo. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis. Gastroenterología y Hepatología (English Edition) 2020; 43(10): 640 doi: 10.1016/j.gastre.2020.03.012
|
64 |
Calvin Q Pan, Lin Zhu, Andy S Yu, Yuchan Zhao, Bo Zhu, Erhei Dai. Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases 2024; 79(4): 953 doi: 10.1093/cid/ciae288
|
65 |
Kumar Visvanathan, Geoff Dusheiko, Michelle Giles, May-Ling Wong, Nghi Phung, Susan Walker, Suong Le, Seng Gee Lim, Ed Gane, Meng Ngu, Winita Hardikar, Ben Cowie, Scott Bowden, Simone Strasser, Miriam Levy, Joe Sasaduesz. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut 2016; 65(2): 340 doi: 10.1136/gutjnl-2015-310317
|
66 |
Calvin Q. Pan, Erhei Dai, Zhongping Duan, Guorong Han, Wenjing Zhao, Yuming Wang, Huaihong Zhang, Baoshen Zhu, Hongxiu Jiang, Shuqin Zhang, Xiaohu Zhang, Huaibin Zou, Xiuli Chen, Yu Chen. Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China. Gut 2022; 71(4): 798 doi: 10.1136/gutjnl-2020-322719
|
67 |
Haruki Komatsu, Ayano Inui. Hepatitis B virus infection in children. Expert Review of Anti-infective Therapy 2015; : 1 doi: 10.1586/14787210.2015.1019867
|
68 |
G. Samadi Kochaksaraei, E. Castillo, M. Osman, K. Simmonds, A. N. Scott, J. I. Oshiomogho, S. S. Lee, R. P. Myers, S. R. Martin, C. S. Coffin. Clinical course of 161 untreated and tenofovir‐treated chronic hepatitisBpregnant patients in a low hepatitisBvirus endemic region. Journal of Viral Hepatitis 2016; 23(1): 15 doi: 10.1111/jvh.12436
|
69 |
Anna L Funk, Ying Lu, Kyoko Yoshida, Tianshuo Zhao, Pauline Boucheron, Judith van Holten, Roger Chou, Marc Bulterys, Yusuke Shimakawa. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. The Lancet Infectious Diseases 2021; 21(1): 70 doi: 10.1016/S1473-3099(20)30586-7
|
70 |
H. Dilek DOĞAN, Çisem BAŞTARCAN. HEPATİT B PREVALANSINDAKİ GİZEM: HEPATİT B ve GEBELİK. Izmir Democracy University Health Sciences Journal 2021; 4(1): 118 doi: 10.52538/iduhes.923716
|
71 |
Jinfeng Liu, Jing Wang, Taotao Yan, Dan Du, Caijing Qi, Furong Cao, Naijuan Yao, Yuan Yang, Yingli He, Zhen Tian, Danfeng Ren, Li Zhu, Tianyan Chen, Yingren Zhao. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real‐life practice. Journal of Viral Hepatitis 2019; 26(10): 1170 doi: 10.1111/jvh.13156
|
72 |
Petr Husa. Therapy of hepatitis B virus (HBV) infection before planned pregnancy, during pregnancy and breastfeeding. Interní medicína pro praxi 2016; 18(1): 24 doi: 10.36290/int.2016.006
|